News
A research team from Southern Medical University has developed a machine learning-based gene model that predicts whether ...
Nasopharyngeal cancer (NPC) arises in the nasopharynx mdash;the upper part of the throat located behind the nose and above ...
4d
News-Medical.Net on MSNMachine learning model predicts radiotherapy response in patients with nasopharyngeal carcinomaResearchers in China have developed a powerful machine learning model that can help determine which patients with nasopharyngeal carcinoma (NPC) are likely to respond well to radiotherapy-a common ...
The approval was based on results from the phase 3 JUPITER-02 trial (ClinicalTrials.gov Identifier: NCT03581786), which included patients with metastatic or recurrent, locally advanced NPC who had ...
Nasopharyngeal carcinoma (NPC), a malignancy that develops in the upper section of the throat behind the nose, occurs in fewer than one person out of 100,000 worldwide each year. Locally advanced ...
Nasopharyngeal carcinoma (NPC) is a malignant tumor originating from the nasopharyngeal epithelium. Due to its concealed location and nonspecific early symptoms, most patients present with lymph ...
The data showed an NPC-specific mortality of 8.2 deaths per 1,000 person-years in the screened group versus 12.5 per 1,000 person-years in the unscreened group, representing a rate ratio of 0.70 ...
The FDA approved a new PD-1 inhibitor, toripalimab (Loqtorzi), for treating adults with metastatic or recurrent nasopharyngeal carcinoma (NPC), representing the first drug specifically approved ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results